Formation Bio
PrivateLast Round
Series D
Jun 26, 2024
Est. Valuation
$1B
Total Funding Raised
$713.5M
Company Overview
Formation Bio is a biotechnology company that operates an AI-native drug development platform to acquire, in-license, and accelerate the development of clinical-stage pharmaceutical assets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Formation Bio Comparables
Compare Formation Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Owkin | 77% | |
| Insilico Medicine | 73% | |
| Eli Lilly and Company | 73% | |
Formation Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jun 26, 2024 | ||||
| Series C | Sep 30, 2021 | ||||
| Series B | Oct 31, 2018 | ||||
| Series B | Oct 1, 2018 | ||||
| Series A | Nov 16, 2017 | ||||
Seed | Nov 1, 2016 |
Key People
Founding team and executive leadership
Formation Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series D |
| S32 | Series C |
| Maveron | Series A, Series B, Seed |
| SV Angel | Series D |
| Founder Collective | Series A, Series B, Seed |
| Thrive Capital | Series C, Series D, Series B |
| Streamlined Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2025
Former Pfizer CSO Mikael Dolsten joins as advisor.
- Jun 26, 2024
$372M round led by Andreessen Horowitz.
Formation Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Formation Bio's valuation, stock price, and market status.